Wednesday, September 28, 2016 1:03:40 PM
As further evidence of Sucanon's efficacy and the reliability of Sucanon studies, Here is a review of "levels of evidence" as we refer to in the medical community.
Level 1through 5 with level 1 being the most reliable studies upon which medical treatment decisions are made.
1. Blinded randomized controlled trial with statistically significant differences and appropriate confidence intervals.
2. Randomized controlled trial without proper randomization, blinding, or poor follow up
3. Case control or retrospective study.
4. Case series. (For example, a paper outlining how I fixed a torn tendon in x number of patients and it worked. The overwhelming majority of published medical literature fits into this category)
5. Expert opinion.
Note that Sucanon outperformed Glyburide in a 6 month randomized double blind placebo controlled trial (the highest level 1 evidence) in terms of fasting blood sugar reduction, excretion of urinary glucose, and glucose tolerance testing.
The trial in prediabetics in which 84% showed normalized HbA1C levels after 12 weeks of Sucanon is level 3 since not placebo controlled but was peer reviewed and presented at the prestigious EASD 2013 annual meeting and published in their journal.
I could claim expert opinion (level 5) based on training but instead claim only that my facts are independently verifiable from public sources so any can check as desired. Note that level 4 and 5 is the usual treatment opinion you get from your doctor if specific higher level evidence is not available or consulted.
Finally, if there is more reliable evidence than level 1 above (double blinded randomized placebo controlled study with statistically significant results, I'm all ears. Other than that the publicly available science speaks for itself
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM